Transpara vs Illumeo System
AI Verdict
Choose Transpara if…
Choose Transpara if your primary goal is to significantly improve the accuracy and efficiency of breast cancer detection in both 2D and 3D mammography. This tool is ideal for radiology departments seeking AI-powered assistance for risk categorization, breast density assessment, and temporal comparisons to enhance radiologist workflow and achieve earlier detection with a high negative predictive value.
View Transpara →Choose Illumeo System if…
Choose Illumeo System if you require a comprehensive imaging and informatics platform that leverages adaptive intelligence to augment clinician skills across a wide range of imaging studies. This system is best suited for institutions looking to enhance diagnostic efficiency, reduce variability, and integrate advanced AI capabilities seamlessly with existing PACS, EMR, and RIS systems, providing contextual awareness and advanced data analytics for a holistic view.
View Illumeo System →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Transpara | Illumeo System |
|---|---|---|
| Pricing | Enterprise | Not publicly available |
| Deployment | On premise | Integrates with existing healthcare IT systems (e.g., Philips IntelliSpace PACS, EMR/RIS); Enterprise viewer is HTML5-based and zero-footprint. |
| FDA Status | Cleared AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Illumeo SystemTool B (Illumeo System) emphasizes 'adaptive intelligence' and 'redefines how they interact with images,' with an HTML5-based, zero-footprint viewer. This deployment model generally offers easier access and less IT overhead, contributing to better usability and flexibility in an enterprise setting compared to Tool A's on-premise model.
Clinical Value
TransparaTool A (Transpara) provides specific and quantifiable clinical benefits in breast cancer detection for 2D and 3D mammography, including temporal comparison, breast density assessment, risk categorization, and a high negative predictive value (99.97%) for low-risk cases. It is explicitly FDA-cleared, offering clear evidence of its clinical utility.
Pricing & Value
TieBoth tools utilize enterprise custom pricing models and require direct contact with the vendor for details. Neither provides any publicly available pricing information, making it impossible to compare their pricing or assess their value proposition based on the available data.
Enterprise Readiness
TieBoth tools exhibit robust enterprise readiness. Tool A (Transpara) has a proven track record with hundreds of leading centers in over 30 countries and has analyzed over 11 million mammograms, alongside API availability and data export. Tool B (Illumeo System) highlights HIPAA compliance, BAA, and seamless integration with existing healthcare IT systems like PACS, EMR/RIS, featuring an HTML5-based, zero-footprint viewer for easy deployment.
Innovation
TransparaTool A (Transpara) demonstrates deep innovation within its specialized field of mammography, offering advanced AI for 2D and 3D detection, temporal comparison, breast density assessment, and risk categorization. Tool B's (Illumeo System) innovative features are described more generally for a broader radiology platform, such as 'Adaptive Intelligence' and 'Contextual Awareness,' which are less specific in their application.
Support & Docs
TieBoth tools appear to offer extensive support and documentation resources. Tool A (Transpara) provides guides, changelogs, tutorials, FAQs, and a knowledge base. Tool B (Illumeo System), as a Philips product, benefits from a comprehensive resource center with product usage documents, regulatory documents, and technical standards. Without more specific details on the quality or responsiveness of support, it is difficult to differentiate them.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Transpara | Illumeo System |
|---|---|---|
| Product Name | Transpara | Illumeo System |
| Company | ScreenPoint Medical B.V. | Philips Medical Systems Technologies |
| Primary Function | Enhances breast cancer detection and optimizes radiologist workflow for 2D and 3D mammography. | Imaging and informatics platform with adaptive intelligence (AI) that augments clinicians' skills and redefines how they interact with images, enhancing their expertise and efficiency, and supporting variability reduction. |
| Core AI Capabilities | AI-powered detection for 2D and 3D mammograms (FFDM and DBT), Temporal Comparison (analyzes current study against up to 3 priors over 6 years), Breast Density assessment (BI-RADS-like and volumetric), Risk categorization (Elevated, Intermediate, Low), Region-based and overall exam scores. | Adaptive Intelligence, Contextual Awareness, Advanced Data Analytics, Anatomy-Aware Capabilities, Intelligent Clinical Semantic Labeling Engine. |
| Clinical Focus | Obstetrics & Gynecology, Radiology (specifically 2D and 3D mammography). | Radiology. |
| Workflow Enhancement | Workflow optimization and workload reduction, Concurrent reading aid for radiologists. | Augments clinicians' skills and redefines how they interact with images, enhancing their expertise and efficiency, and supporting variability reduction. |
| API Availability / Data Export | API available: yes; Data export: yes. | Not specified |
Videos
Demos, reviews, and walkthroughs featuring Transpara and Illumeo System.